Lyka Labs Limited

Lyka Labs Limited

Performance

Today's Low Today's High
153.21 153.75
158.00 158.05
52 Week Low 52 Week High
97.90 (04-Jun-2024) 99.95 (04-Jun-2024)
172.50 (06-Sep-2024) 172.65 (06-Sep-2024)

Open
155.65 156.90
Previous Close
154.96 154.75
Volume
1.40
Total Traded value
2.19 (₹ Lakhs)
Upper circuit
185.95 132.05
Lower circuit
123.96 119.55

Market Depth

Buy Order Quantity Sell Order Quantity
2,845
0

Bid PriceQuantity
156.572,845.00
0.000.00
0.000.00
0.000.00
0.000.00
Total:2,845
Ask PriceQuantity
0.000.00
0.000.00
0.000.00
0.000.00
0.000.00
Total:--

Fundamentals

Market Cap: ₹5.64 Cr
PE Ratio (TTM): 459.49
PB Ratio: 5.56
Industry P/E:506.53
Debt to Equity:-
ROE:1.21
EPS (TTM):0.34
Book Value:0.00
Face Value: 10.00

Financials

Jun, 2023Dec, 2022Jun, 2023Dec, 2022Sep, 2022
Revenue105.35 Cr420.16 Cr94.79 Cr105.73 Cr22.13 Cr
Profit129.69 Cr17.49 Cr13.31 Cr4.26 Cr-0.40 Cr
Expense138.68 Cr358.32 Cr91.78 Cr101.45 Cr23.77 Cr
Comprehensive income129.69 Cr17.49 Cr13.69 Cr4.31 Cr-0.43 Cr
EPS29.621.430.097.16-0.15
Lyka Labs Limited is a renowned pharmaceutical company based in Mumbai, India. With a strong focus on research and development, the company specializes in the development, manufacturing, and marketing of pharmaceutical formulations and active pharmaceutical ingredients across a wide range of therapeutic segments.

The company's diverse product portfolio includes various formulations such as emollients, topical steroids, antifungal agents, topical anti-bacterials, acne management solutions, dermatological formulations, pain killers, anti-aging products, cleansing lotions, hair care products, anti-dandruff shampoos, sunscreens, anti-acne treatments, cosmeceuticals, anti-oxidants, proton pump inhibitors, anti-malarials, anti-bacterials, corticosteroid hormones, cephalosporins, dry powder injections, bone resorption inhibitors, anti-oxidant/liver disease treatments, antibiotics, and lyophilized products.

In addition to its extensive product range, Lyka Labs Limited also offers contracted manufacturing services to various large pharmaceutical companies. It provides valuable medical and technical assistance in areas such as manufacturing know-how, manufacturing facilities, and technical data including molecule stability testing data, impurity profiles, and BA/BE clinical study data.

The company caters to a wide range of therapeutic categories, including intensive care, gastroenterology, anti-infective, anti-fungal, surgery care, cosmetology, urology, wound care, and anesthesia. Its products are available in various forms such as injections, creams, ointments, foams, gels, and lotions.

With a rich history dating back to its incorporation in 1976, Lyka Labs Limited continues to be a leading player in the pharmaceutical industry, both domestically and internationally.
Company nameListing dateIndustry NSE symbol BSE symbol
Lyka Labs Limited Feb, 1995 Jun, 1986 Pharmaceuticals Pharmaceuticals LYKALABS LYKALABS

Shareholding pattern

Sep, 2023 Jun, 2023 Apr, 2023 Mar, 2023 Mar, 2023

  • Promoters 
    54.81%
    Public 
    45.19%
    Shares held by Employee Trusts 
    0.00%
  • Promoters 
    54.58%
    Public 
    45.42%
    Shares held by Employee Trusts 
    0.00%
  • Promoters 
    54.56%
    Public 
    45.44%
    Shares held by Employee Trusts 
    0.00%
  • Promoters 
    51.00%
    Public 
    49.00%
    Shares held by Employee Trusts 
    0.00%
  • Promoters 
    51.00%
    Public 
    49.00%
    Shares held by Employee Trusts 
    0.00%

Lyka Labs Limited FAQ's

What is the range of today's stock performance for Lyka Labs Limited?

Today's stock performance witnessed a fluctuation from a minimum of 153.21 on the NSE (National Stock Exchange) to a maximum of 158.00. Similarly, on the BSE (Bombay Stock Exchange), the stock's intraday range extended from a low of 153.75 to a high of 158.05.

What are the 52-week low and high values for Lyka Labs Limited?

The stock's performance over the past 52 weeks reveals a low of 97.90 (occurred on 04-Jun-2024) and a high of 172.50 (achieved on 06-Sep-2024) on the NSE (National Stock Exchange). Similarly, on the BSE (Bombay Stock Exchange), the 52-week low is 99.95 (on 04-Jun-2024), and the 52-week high is 172.65 (on 06-Sep-2024).

What was the opening and previous closing prices for Lyka Labs Limited?

The stock's performance over the past 52 weeks reveals a low of 97.90 (occurred on 04-Jun-2024) and a high of 172.50 (achieved on 06-Sep-2024) on the NSE (National Stock Exchange). Similarly, on the BSE (Bombay Stock Exchange), the 52-week low is 99.95 (on 04-Jun-2024), and the 52-week high is 172.65 (on 06-Sep-2024).

What is the total volume and traded value for Lyka Labs Limited for the day?

The total volume is 1, and the total traded value is 2.19 (₹ Lakhs).

What are the upper and lower circuit limits for Lyka Labs Limited?

The upper circuit limit is 185.95, and the lower circuit limit is 123.96.

What is the market cap and PE ratio for Lyka Labs Limited?

The market cap is ₹5.64 Cr, and the PE ratio (TTM) is 1,002.81.

What are the financial metrics such as ROE, EPS, dividend yield, book value, and face value for Lyka Labs Limited?

ROE is 1.21, EPS is 0.34, book value is not available

What are the revenue and profit figures for the latest quarter and previous quarters for Lyka Labs Limited?

In Jun 2023, Revenue is ₹1053500000.00, and Profit is ₹1296900000.00. In Dec 2022, Revenue is ₹4201593000.00, and Profit is ₹174919000.00.

When was Lyka Labs Limited listed, and what industry does it belong to?

The company, Lyka Labs Limited, was listed in Feb 1995 and belongs to the Pharmaceuticals industry. Its NSE symbol is LYKALABS.

What is the current shareholding pattern of the Lyka Labs Limited?

As of latest available update, promoters hold 54.81%, the public holds 45.19%, and Employee Trusts holds 0.00.

The Indian Community

Public Community

Discover the vibrant tapestry of 'The Indian Community' - a melting pot of diverse cultures, traditions, and values. Explore its rich heritage, festivals, and contributions, as this online hub celebrates the essence of India's people, connecting, inspiring, and fostering unity worldwide.

Members
18
online
962
Threads
32
Settings

Latest Business News

Back
Top